CME Group Inc. · CME · Next earnings

CME Group Inc. reports Wednesday, Oct 21, 2026

CME reports before market open with consensus EPS at $2.96 and revenue at $1.69B. Last quarter: CME Group Q2: Record Revenue, Robust Product Pipeline, CFTC Overhang

Reports Before market open31 days awayDate estimated Financial Services

What the street expects

Consensus for the coming report
Consensus EPS $2.96 Calendar consensus
Consensus revenue $1.69B Calendar consensus
Report date Oct 21, 2026 Wednesday, date estimated
Session Before market open 31 days away

Where CME left off: FY2026 Q2

Full report

CME Group Q2: Record Revenue, Robust Product Pipeline, CFTC Overhang

EPS surprise +2.7% Reported $2.99 vs $2.91
Revenue surprise +1.4% Reported $1.71B vs $1.68B
Stock move +5.0% Event window
Subsequent drift +4.3% Up to 20 sessions

Guidance was maintained from the prior quarter. Management did not raise or lower forward expectations but expressed confidence in the growth trajectory driven by the product pipeline and institutional demand. Capex outlook was not mentioned this quarter, compared to an increasing outlook in Q1.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • CFTC litigation outcome could delay or restrict 24/7 and perpetual futures offerings.
  • Regulatory uncertainty surrounding perpetual and 24/7 contract approvals.
  • Competition from crypto exchanges offering perpetual contracts.
  • Reliance on institutional demand; retail expansion remains uncertain.
  • Potential market-manipulation risk in perpetual products.

Questions analysts left open

  • Level of demand and regulatory approval for perpetual futures.
  • Timing and CFTC approval of 24/7 contracts (e.g., crude vs. gold).
  • Competitive pressure from crypto perpetual markets.
  • Potential impact of CFTC litigation timeline on operations.
  • Effect of market-data pricing changes on client cost structures.

Ask FN2 about CME next report

Transcript, numbers and history already loaded
What should I watch for in CME's next earnings report?How did CME guide last quarter, and is consensus above or below that?Give me the bull and bear case going into CME earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the CME recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent CME quarters

All CME earnings
+5.0%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q2

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.